These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of clotrimazol treatment on the demethylation of mestranol. Bolt HM; Kappus H Horm Metab Res; 1973 May; 5(3):234. PubMed ID: 4714556 [No Abstract] [Full Text] [Related]
25. Multiple septic complications of disseminated candidiasis following anorectal sepsis in a non-immunocompromised patient. Salemis NS; Tsolakis K; Aloizos S; Tsohataridis E Int J Infect Dis; 2008 Nov; 12(6):e155-7. PubMed ID: 18674943 [No Abstract] [Full Text] [Related]
26. Topical clotrimazole in dermatophytosis. David LM; Veien NK; Schmidt JD; Murtishaw W; Smith EB Curr Ther Res Clin Exp; 1973 Mar; 15(3):133-7. PubMed ID: 4196230 [No Abstract] [Full Text] [Related]
27. [1st clinical experiences in systemic mycoses with a new oral antimycotic drug]. Oberste-Lehn H; Baggesen I; Plempel M Mykosen; 1970 Jan; 13(1):1-12. PubMed ID: 5480480 [No Abstract] [Full Text] [Related]
28. Urinary candidiasis after renal transplantation. Cartwright RY; Shaldon C; Hall GH Br Med J; 1972 May; 2(5809):351. PubMed ID: 4553822 [No Abstract] [Full Text] [Related]
29. [Arterial thromboembolism in candida albicans sepsis. Surgical problems in candida septicemia]. Sandmann W; Müller E Dtsch Med Wochenschr; 1974 Dec; 99(49):2512-3, 2519-22. PubMed ID: 4611705 [No Abstract] [Full Text] [Related]
30. [Successful treatment of candida sepsis with the oral antimycotic Bay b 5097]. Malchow H; Seybold D; Lange H; Freund J; Rüger K Dtsch Med Wochenschr; 1972 Jun; 97(24):935-8. PubMed ID: 4503519 [No Abstract] [Full Text] [Related]
31. [Metastatic ophthalmia following candida septicemia. Experiences with the new oral antimycotic drug Bay b 5097]. Freund J; Rüger K; Malchow H Klin Monbl Augenheilkd; 1972 Jul; 161(1):82-8. PubMed ID: 4539093 [No Abstract] [Full Text] [Related]
32. [Fungal infections: involved species and minimal inhibitory concentrations of common antifungal agents]. Dei-Cas E; Fruit J; Poulain D; Dutoit E; Chendid H; Vernes A Ann Biol Clin (Paris); 1984; 42(6):415-8. PubMed ID: 6543419 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of ketoconazole. Sohn CA Clin Pharm; 1982; 1(3):217-24. PubMed ID: 6309466 [TBL] [Abstract][Full Text] [Related]
34. [Septicemia due to candida albicans. Pathogenesis, diagnosis, and chemotherapy]. Rosin H Dtsch Med Wochenschr; 1974 Dec; 99(49):2514, 2526-30. PubMed ID: 4611706 [No Abstract] [Full Text] [Related]
35. [Choice and use of antifungal drugs]. Dupont B Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672 [TBL] [Abstract][Full Text] [Related]
36. [Preliminary report on the therapeutic results using BAY b 5097 in lung patients with a candida positive sputum]. Riska N; Fröseth B; Mattson K; Nordman CH Pneumonologie; 1971; 145():406-16. PubMed ID: 4942799 [No Abstract] [Full Text] [Related]
37. [Ketoconazole]. Cuena Boy R; Azanza Perea JR; Honorato Pérez JM Rev Med Univ Navarra; 1982 Sep; 26(3):193-4. PubMed ID: 6302808 [No Abstract] [Full Text] [Related]
38. [Guideline for diagnosis and treatment of deep mycosis]. Kono S Rinsho Ketsueki; 2001 Jun; 42(6):452-7. PubMed ID: 11505521 [No Abstract] [Full Text] [Related]
39. [Recommendations of antifungal treatment in patients with low grade immunosuppression]. Barberán J; Mensa J; Fariñas C; Llinares P; Serrano R; Menéndez R; Agustí C; Gobernado M; Azanza JR; García Rodríguez JA; ; ; Rev Esp Quimioter; 2008 Jun; 21(2):127-42. PubMed ID: 18509772 [TBL] [Abstract][Full Text] [Related]